Literature DB >> 9210217

Interactions between dystrophin and the sarcolemma membrane.

J S Chamberlain1, K Corrado, J A Rafael, G A Cox, M Hauser, C Lumeng.   

Abstract

Dystrophin serves as a link between the subsarcolemmal cytoskeleton and the extracellular matrix. The NH2 terminus attaches to the cytoskeleton, while the COOH terminus attaches to the dystrophin associated protein (DAP) complex, which can be separated into the dystroglycan, sarcoglycan, and syntrophin subcomplexes. While the function of each DAP is not known, the dystroglycan complex binds laminin in the extracellular matrix, and binds the dystrophin COOH terminus in vitro. The syntrophins also bind the dystrophin COOH terminus in vitro, but no evidence has been reported for an interaction between dystrophin and the sarcoglycans. Human mutations have been found in dystrophin, the sarcoglycans and laminin, all of which lead to various types of muscular dystrophy. We have been studying the dystrophin domains necessary for formation of a functional complex by generating transgenic mdx (dystrophin minus) mice expressing internally truncated dystrophins. These mice provide in vivo models to study the localization of truncated dystrophin isoforms, the association of the truncated proteins with the DAP complex, and the functional capacity of the assembled DAP complexes. Expression of a dystrophin deleted for most of the NH2-terminal domain in mdx mice leads to only a mild dystrophy, indicating that dystrophin can attach to the cytoskeleton by multiple mechanisms. Truncation of the central rod domain leads to normal DAP complex formation and almost fully prevents development of dystrophy. Deletion analysis of the COOH-terminal regions indicates that a broad cysteine-rich domain is indispensable for dystrophin function. This region coincides with the in vitro identified beta-dystroglycan binding domain. Mice lacking this latter domain express very low levels of the sarcoglycans, indicating that the sarcoglycan complex binds dystrophin via dystroglycan. All deletion constructs tested lead to normal expression of the syntrophins, indicating that syntrophin associates with the DAP complex via multiple binding partners.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210217

Source DB:  PubMed          Journal:  Soc Gen Physiol Ser        ISSN: 0094-7733


  10 in total

1.  Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.

Authors:  Gyula Acsadi; Steven A Moore; Angélique Chéron; Olivier Delalande; Lindsey Bennett; William Kupsky; Mohammad El-Baba; Elisabeth Le Rumeur; Jean-François Hubert
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

Authors:  Sue Fletcher; Abbie M Adams; Russell D Johnsen; Kane Greer; Hong M Moulton; Steve D Wilton
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

3.  Dp71f modulates GSK3-beta recruitment to the beta1-integrin adhesion complex.

Authors:  Joel Cerna Cortés; Eliud Alfredo Garcia Montalvo; Jesús Muñiz; Dominique Mornet; Efrain Garrido; Federico Centeno; Bulmaro Cisneros
Journal:  Neurochem Res       Date:  2008-08-02       Impact factor: 3.996

4.  The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.

Authors:  S Gattenloehner; A Vincent; I Leuschner; S Tzartos; H K Müller-Hermelink; T Kirchner; A Marx
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins.

Authors:  Patrice Fort; Francisco-Javier Estrada; Agnès Bordais; Dominique Mornet; José-Alain Sahel; Serge Picaud; Haydeé Rosas Vargas; Ramón M Coral-Vázquez; Alvaro Rendon
Journal:  Neurosci Res       Date:  2005-09       Impact factor: 3.304

6.  The expression of dystrophin and alpha1-syntrophin during skeletal muscle regeneration.

Authors:  S Hoshino; N Ohkoshi; A Ishii; S Kameya; S Takeda; S Shoji
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

7.  Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice.

Authors:  Lampros Panagis; Xiujun Zhao; Yongchao Ge; Lizhen Ren; Thomas W Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-08       Impact factor: 4.799

8.  Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.

Authors:  Susan C Brown; Silvia Torelli; Martin Brockington; Yeliz Yuva; Cecilia Jimenez; Lucy Feng; Louise Anderson; Isabella Ugo; Stephan Kroger; Kate Bushby; Thomas Voit; Caroline Sewry; Francesco Muntoni
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

9.  Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database.

Authors:  Aurélie Nicolas; Céline Lucchetti-Miganeh; Rabah Ben Yaou; Jean-Claude Kaplan; Jamel Chelly; France Leturcq; Frédérique Barloy-Hubler; Elisabeth Le Rumeur
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

10.  X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.

Authors:  Inès Barthélémy; Nadège Calmels; Robert B Weiss; Laurent Tiret; Adeline Vulin; Nicolas Wein; Cécile Peccate; Carole Drougard; Christophe Beroud; Nathalie Deburgrave; Jean-Laurent Thibaud; Catherine Escriou; Isabel Punzón; Luis Garcia; Jean-Claude Kaplan; Kevin M Flanigan; France Leturcq; Stéphane Blot
Journal:  Skelet Muscle       Date:  2020-08-07       Impact factor: 4.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.